Thanks for finding and sharing that. Makes sense. Valuation without FDA is still very respectable.
It also nicely describes how the 'risk-free rate of return' impacts stock prices, esp the high growth / IT / biomed stocks have fallen so much.
FDA APPROVAL, page-20
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.75 |
Change
0.110(6.71%) |
Mkt cap ! $194.4M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.75 | $1.64 | $72.69K | 42.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4317 | $1.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.75 | 12891 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| CYC (ASX) Chart |